View select recent tuberculosis publications from TRTC investigators

1.

Perceptions of drones, digital adherence monitoring technologies and educational videos for tuberculosis control in remote Madagascar: a mixed-method study protocol.

 

Nouvet E, Knoblauch AM, Passe I, Andriamiadanarivo A, Ravelona M, Ainanomena Ramtariharisoa F, Razafimdriana K, Wright PC, McKinney J, Small PM, Rakotosamimanana N, Grandjean Lapierre S.

 

BMJ Open. 2019 May 9;9(5):e028073. doi: 10.1136/bmjopen-2018-028073.

 

PMID: 31076475 [PubMed - in process] Free Article

 

Similar articles

 

2.

Dual-targeting GroEL/ES chaperonin and protein tyrosine phosphatase B (PtpB) inhibitors: A polypharmacology strategy for treating Mycobacterium tuberculosis infections.

 

Washburn A, Abdeen S, Ovechkina Y, Ray AM, Stevens M, Chitre S, Sivinski J, Park Y, Johnson J, Hoang QQ, Chapman E, Parish T, Johnson SM.

 

Bioorg Med Chem Lett. 2019 Apr 24. pii: S0960-894X(19)30254-9. doi: 10.1016/j.bmcl.2019.04.034. [Epub ahead of print]

 

PMID: 31047750 [PubMed - as supplied by publisher]

 

Similar articles

 

3.

Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase.

 

Crespo RA, Dang Q, Zhou NE, Guthrie LM, Snavely TC, Dong W, Loesch KA, Suzuki T, You L, Wang W, O'Malley T, Parish T, Olsen DB, Sacchettini JC.

 

J Med Chem. 2019 May 9;62(9):4483-4499. doi: 10.1021/acs.jmedchem.9b00020. Epub 2019 Apr 19.

 

PMID: 31002508 [PubMed - in process] Free PMC Article

 

Similar articles

 

4.

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.

 

Penn-Nicholson A, Hraha T, Thompson EG, Sterling D, Mbandi SK, Wall KM, Fisher M, Suliman S, Shankar S, Hanekom WA, Janjic N, Hatherill M, Kaufmann SHE, Sutherland J, Walzl G, De Groote MA, Ochsner U, Zak DE, Scriba TJ; ACS and GC6–74 cohort study groups.

 

PLoS Med. 2019 Apr 16;16(4):e1002781. doi: 10.1371/journal.pmed.1002781. eCollection 2019 Apr.

 

PMID: 30990820 [PubMed - in process] Free PMC Article

 

Similar articles

 

5.

Characterization of MenA (isoprenyl diphosphate:1,4-dihydroxy-2-naphthoate isoprenyltransferase) from Mycobacterium tuberculosis.

 

Dhiman RK, Pujari V, Kincaid JM, Ikeh MA, Parish T, Crick DC.

 

PLoS One. 2019 Apr 12;14(4):e0214958. doi: 10.1371/journal.pone.0214958. eCollection 2019.

 

PMID: 30978223 [PubMed - in process] Free PMC Article

 

Similar articles

 

6.

Tuberculosis in Older Adults: Seattle & King County, Washington.

 

Gardner Toren K, Spitters C, Pecha M, Bhattarai S, Horne DJ, Narita M.

 

Clin Infect Dis. 2019 Apr 12. pii: ciz306. doi: 10.1093/cid/ciz306. [Epub ahead of print]

 

PMID: 30977788 [PubMed - as supplied by publisher]

 

Similar articles

 

7.

Novel MenA inhibitors are bactericidal against <i>Mycobacterium tuberculosis</i> and synergize with electron-transport chain inhibitors.

 

Berube BJ, Russell D, Castro L, Choi SR, Narayanasamy P, Parish T.

 

Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02661-18. doi: 10.1128/AAC.02661-18. [Epub ahead of print]

 

PMID: 30962346 [PubMed - as supplied by publisher] Free Article

 

Similar articles

 

8.

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

 

Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, Hallett TB, Hanson CL, Harrington M, Herbert N, Hopewell PC, Ikeda C, Jamison DT, Khan AJ, Koek I, Krishnan N, Motsoaledi A, Pai M, Raviglione MC, Sharman A, Small PM, Swaminathan S, Temesgen Z, Vassall A, Venkatesan N, van Weezenbeek K, Yamey G, Agins BD, Alexandru S, Andrews JR, Beyeler N, Bivol S, Brigden G, Cattamanchi A, Cazabon D, Crudu V, Daftary A, Dewan P, Doepel LK, Eisinger RW, Fan V, Fewer S, Furin J, Goldhaber-Fiebert JD, Gomez GB, Graham SM, Gupta D, Kamene M, Khaparde S, Mailu EW, Masini EO, McHugh L, Mitchell E, Moon S, Osberg M, Pande T, Prince L, Rade K, Rao R, Remme M, Seddon JA, Selwyn C, Shete P, Sachdeva KS, Stallworthy G, Vesga JF, Vilc V, Goosby EP.

 

Lancet. 2019 Mar 30;393(10178):1331-1384. doi: 10.1016/S0140-6736(19)30024-8. Epub 2019 Mar 20. Review. No abstract available.

 

PMID: 30904263 [PubMed - indexed for MEDLINE]

 

Similar articles

 

9.

8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.

 

Odingo JO, Early JV, Smith J, Johnson J, Bailey MA, Files M, Guzman J, Ollinger J, Korkegian A, Kumar A, Ovechkina Y, Parish T.

 

Drug Dev Res. 2019 Mar 20. doi: 10.1002/ddr.21531. [Epub ahead of print]

 

PMID: 30893501 [PubMed - as supplied by publisher]

 

Similar articles

 

10.

The way forward for tuberculosis vaccines.

 

White RG, Hanekom WA, Vekemans J, Harris RC.

 

Lancet Respir Med. 2019 Mar;7(3):204-206. doi: 10.1016/S2213-2600(19)30040-2. No abstract available. Erratum in: Lancet Respir Med. 2019 Apr;7(4):e15.

 

PMID: 30823973 [PubMed - in process]

 

Similar articles

 

11.

Poor supply chain management and stock-outs of point-of-care diagnostic tests in Upper East Region's primary healthcare clinics, Ghana.

 

Kuupiel D, Tlou B, Bawontuo V, Drain PK, Mashamba-Thompson TP.

 

PLoS One. 2019 Feb 27;14(2):e0211498. doi: 10.1371/journal.pone.0211498. eCollection 2019.

 

PMID: 30811407 [PubMed - in process] Free PMC Article

 

Similar articles

 

12.

The relevance of persisters in tuberculosis drug discovery.

 

Mandal S, Njikan S, Kumar A, Early JV, Parish T.

 

Microbiology. 2019 May;165(5):492-499. doi: 10.1099/mic.0.000760. Epub 2019 Feb 18.

 

PMID: 30775961 [PubMed - in process]

 

Similar articles

 

13.

The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.

 

Baldwin SL, Larsen SE, Ordway D, Cassell G, Coler RN.

 

PLoS Negl Trop Dis. 2019 Feb 14;13(2):e0007083. doi: 10.1371/journal.pntd.0007083. eCollection 2019 Feb. Review.

 

PMID: 30763316 [PubMed - indexed for MEDLINE] Free PMC Article

 

Similar articles

 

14.

Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance.

 

Adams KN, Verma AK, Gopalaswamy R, Adikesavalu H, Singhal DK, Tripathy S, Ranganathan UD, Sherman DR, Urdahl KB, Ramakrishnan L, Hernandez RE.

 

J Infect Dis. 2019 Apr 19;219(10):1554-1558. doi: 10.1093/infdis/jiy710.

 

PMID: 30753612 [PubMed - in process] Free PMC Article

 

Similar articles

 

15.

Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model.

 

Robertson GT, Ektnitphong VA, Scherman MS, McNeil MB, Dennison D, Korkegian A, Smith AJ, Halladay J, Carter DS, Xia Y, Zhou Y, Choi W, Berry PW, Mao W, Hernandez V, Alley MRK, Parish T, Lenaerts AJ.

 

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e02071-18. doi: 10.1128/AAC.02071-18. Print 2019 Apr.

 

PMID: 30745397 [PubMed - in process] Free Article

 

Similar articles

 

16.

Associations Between Anxiety and Adherence to Antiretroviral Medications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.

 

Wykowski J, Kemp CG, Velloza J, Rao D, Drain PK.

 

AIDS Behav. 2019 Jan 18. doi: 10.1007/s10461-018-02390-8. [Epub ahead of print] Review.

 

PMID: 30659424 [PubMed - as supplied by publisher]

 

Similar articles

 

17.

A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis.

 

Ollinger J, Kumar A, Roberts DM, Bailey MA, Casey A, Parish T.

 

PLoS One. 2019 Jan 16;14(1):e0205479. doi: 10.1371/journal.pone.0205479. eCollection 2019.

 

PMID: 30650074 [PubMed - in process] Free PMC Article

 

Similar articles

 

18.

Remembering the Host in Tuberculosis Drug Development.

 

Frank DJ, Horne DJ, Dutta NK, Shaku MT, Madensein R, Hawn TR, Steyn AJC, Karakousis PC, Kana BD, Meintjes G, Laughon B, Tanvir Z.

 

J Infect Dis. 2019 Apr 19;219(10):1518-1524. doi: 10.1093/infdis/jiy712.

 

PMID: 30590592 [PubMed - in process]

 

Similar articles

 

19.

Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis.

 

Early J, Ollinger J, Darby C, Alling T, Mullen S, Casey A, Gold B, Ochoada J, Wiernicki T, Masquelin T, Nathan C, Hipskind PA, Parish T.

 

ACS Infect Dis. 2019 Feb 8;5(2):272-280. doi: 10.1021/acsinfecdis.8b00256. Epub 2018 Dec 17.

 

PMID: 30501173 [PubMed - in process] Free PMC Article

 

Similar articles

 

20.

Advancing Translational Science for Pulmonary Nontuberculous Mycobacterial Infections. A Road Map for Research.

 

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM.

 

Am J Respir Crit Care Med. 2019 Apr 15;199(8):947-951. doi: 10.1164/rccm.201807-1273PP. No abstract available.

 

PMID: 30428263 [PubMed - in process]

 

Similar articles

 

21.

Monocyte-to-Lymphocyte Ratio Is Associated With Tuberculosis Disease and Declines With Anti-TB Treatment in HIV-Infected Children.

 

Choudhary RK, Wall KM, Njuguna I, Pavlinac PB, LaCourse SM, Otieno V, Gatimu J, Stern J, Maleche-Obimbo E, Wamalwa D, John-Stewart G, Cranmer LM.

 

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):174-181. doi: 10.1097/QAI.0000000000001893.

 

PMID: 30399036 [PubMed - in process]

 

Similar articles

 

22.

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial.

 

Suliman S, Luabeya AKK, Geldenhuys H, Tameris M, Hoff ST, Shi Z, Tait D, Kromann I, Ruhwald M, Rutkowski KT, Shepherd B, Hokey D, Ginsberg AM, Hanekom WA, Andersen P, Scriba TJ, Hatherill M; H56-035 Trial Group.

 

Am J Respir Crit Care Med. 2019 Jan 15;199(2):220-231. doi: 10.1164/rccm.201802-0366OC.

 

PMID: 30092143 [PubMed - in process]

 

Similar articles

 

Older publications:

1.

The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases.

 

Baldwin SL, Larsen SE, Ordway D, Cassell G, Coler RN.

 

PLoS Negl Trop Dis. 2019 Feb 14;13(2):e0007083. doi: 10.1371/journal.pntd.0007083. eCollection 2019 Feb. Review.

 

PMID: 30763316 [PubMed - in process] Free Article

 

Similar articles

 

2.

Efficacy and improved resistance potential of a cofactor-independent InhA inhibitor of <i>Mycobacterium tuberculosis</i> in a C3HeB/FeJ mouse model.

 

Robertson GT, Ektnitphong VA, Scherman MS, McNeil MB, Dennison D, Korkegian A, Smith AJ, Halladay J, Carter DS, Xia Y, Zhou Y, Choi W, Berry P, Mao W, Hernandez V, Alley MRK, Parish T, Lenaerts AJ.

 

Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.02071-18. doi: 10.1128/AAC.02071-18. [Epub ahead of print]

 

PMID: 30745397 [PubMed - as supplied by publisher] Free Article

 

Similar articles

 

3.

A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis.

 

Ollinger J, Kumar A, Roberts DM, Bailey MA, Casey A, Parish T.

 

PLoS One. 2019 Jan 16;14(1):e0205479. doi: 10.1371/journal.pone.0205479. eCollection 2019.

 

PMID: 30650074 [PubMed - in process] Free PMC Article

 

Similar articles

 

4.

Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort.

 

Bajema KL, Bassett IV, Coleman SM, Ross D, Freedberg KA, Wald A, Drain PK.

 

BMC Infect Dis. 2019 Jan 5;19(1):14. doi: 10.1186/s12879-018-3614-7.

 

PMID: 30611192 [PubMed - indexed for MEDLINE] Free PMC Article

 

Similar articles

 

5.

Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria.

 

Graustein AD, Misch EA, Musvosvi M, Shey M, Shah JA, Seshadri C, Aguoju A, Bowman K, Mulenga H, Veldsman A, Hanekom WA, Hatherill M, Scriba TJ, Hawn TR.

 

PLoS One. 2018 Dec 14;13(12):e0208940. doi: 10.1371/journal.pone.0208940. eCollection 2018.

 

PMID: 30550567 [PubMed - in process] Free PMC Article

 

Similar articles

 

6.

Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis.

 

Early J, Ollinger J, Darby C, Alling T, Mullen S, Casey A, Gold B, Ochoada J, Wiernicki T, Masquelin T, Nathan C, Hipskind PA, Parish T.

 

ACS Infect Dis. 2019 Feb 8;5(2):272-280. doi: 10.1021/acsinfecdis.8b00256. Epub 2018 Dec 17.

 

PMID: 30501173 [PubMed - in process] Free PMC Article

 

Similar articles

 

7.

DORA Editorial.

 

Parish T, Harris M, Fry N, Mathee K, Trujillo ME, Bentley S, Thomson N.

 

Microbiology. 2019 Feb;165(2):125-126. doi: 10.1099/mic.0.000751. Epub 2018 Dec 5. No abstract available.

 

PMID: 30516468 [PubMed - in process]

 

Similar articles

 

8.

DORA Editorial.

 

Parish T, Harris M, Fry N, Mathee K, Trujillo ME, Bentley S, Thomson N.

 

J Gen Virol. 2019 Jan;100(1):1-2. doi: 10.1099/jgv.0.001191. Epub 2018 Dec 5. No abstract available.

 

PMID: 30516467 [PubMed - in process]

 

Similar articles

 

9.

DORA Editorial.

 

Parish T, Harris M, Fry N, Mathee K, Trujillo ME, Bentley S, Thomson N.

 

J Med Microbiol. 2019 Feb;68(2):117-118. doi: 10.1099/jmm.0.000887. Epub 2018 Dec 5. No abstract available.

 

PMID: 30516466 [PubMed - in process]

 

Similar articles

 

10.

DORA Editorial.

 

Parish T, Harris M, Fry N, Mathee K, Trujillo ME, Bentley S, Thomson N.

 

Microb Genom. 2018 Dec;4(12). doi: 10.1099/mgen.0.000238. Epub 2018 Dec 5. No abstract available.

 

PMID: 30516464 [PubMed - in process] Free Article

 

Similar articles

 

11.

DORA Editorial.

 

Parish T, Harris M, Fry N, Mathee K, Trujillo ME, Bentley S, Thomson N.

 

Int J Syst Evol Microbiol. 2019 Jan;69(1):1-2. doi: 10.1099/ijsem.0.003172. No abstract available.

 

PMID: 30516461 [PubMed - in process]

 

Similar articles

 

12.

Advancing Translational Science for Pulmonary NTM Infections: A Roadmap for Research.

 

Daniel-Wayman S, Abate G, Barber DL, Bermudez LE, Coler RN, Cynamon MH, Daley CL, Davidson RM, Dick T, Floto RA, Henkle E, Holland SM, Jackson M, Lee RE, Nuermberger EL, Olivier KN, Ordway DJ, Prevots DR, Sacchettini JC, Salfinger M, Sassetti CM, Sizemore CF, Winthrop KL, Zelazny AM.

 

Am J Respir Crit Care Med. 2018 Nov 14. doi: 10.1164/rccm.201807-1273PP. [Epub ahead of print]

 

PMID: 30428263 [PubMed - as supplied by publisher]

 

Similar articles

 

13.

Monocyte-to-Lymphocyte Ratio Is Associated With Tuberculosis Disease and Declines With Anti-TB Treatment in HIV-Infected Children.

 

Choudhary RK, Wall KM, Njuguna I, Pavlinac PB, LaCourse SM, Otieno V, Gatimu J, Stern J, Maleche-Obimbo E, Wamalwa D, John-Stewart G, Cranmer LM.

 

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):174-181. doi: 10.1097/QAI.0000000000001893.

 

PMID: 30399036 [PubMed - in process]

 

Similar articles

 

14.

Going beyond gamma for TB protection.

 

Cohen SB, Urdahl KB.

 

Nat Microbiol. 2018 Nov;3(11):1194-1195. doi: 10.1038/s41564-018-0266-8. No abstract available.

 

PMID: 30356152 [PubMed - in process]

 

Similar articles

 

15.

Activation of 2,4-Diaminoquinazoline in <i>Mycobacterium tuberculosis</i> by Rv3161c, a Putative Dioxygenase.

 

Melief E, Bonnett SA, Zuniga ES, Parish T.

 

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01505-18. doi: 10.1128/AAC.01505-18. Print 2019 Jan.

 

PMID: 30323042 [PubMed - in process] Free PMC Article

 

Similar articles